| Record ID | marc_loc_2016/BooksAll.2016.part21.utf8:219528221:1250 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part21.utf8:219528221:1250?format=raw |
LEADER: 01250cam a2200349 a 4500
001 92049430
003 DLC
005 19930202095523.8
008 920902s1992 gw a b 000 0 eng c
010 $a 92049430
020 $a3540559531 (Berlin : acid-free paper) :$cDM118.00
020 $a0387559531 (New York : acid-free paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.I45$bL945 1992
060 $aQZ 266 L9863
082 00 $a616.99/4061$220
245 00 $aLymphohaematopoietic growth factors in cancer therapy II /$cR. Mertelsmann, ed.
260 $aBerlin ;$aNew York :$bSpringer-Verlag,$cc1992.
300 $a123 p. :$bill. ;$c29 cm.
490 1 $aMonographs / European School of Oncology
504 $aIncludes bibliographical references.
650 0 $aCancer$xImmunotherapy.
650 0 $aHematopoietic growth factors$xTherapeutic use.
650 0 $aInterleukins$xTherapeutic use.
650 0 $aLymphokines$xTherapeutic use.
650 2 $aGrowth Substances.
650 2 $aInterleukin-2$xtherapeutic use.
650 2 $aInterleukins$xtherapeutic use.
650 2 $aKiller Cells, Lymphokine-Activated.
650 2 $aNeoplasms$xtherapy.
700 10 $aMertelsmann, Roland.
830 0 $aMonographs (European School of Oncology)